SARS-CoV-2-specific T cell responses are not associated with protection against reinfection in hemodialysis patients.
Author
Shankar, SushmaBeckett, Joseph
Tipton, Tom
Ogbe, Ane
Kasanyinga, Mwila
Dold, Christina
Lumley, Sheila
Dengu, Fungai
Rompianesi, Gianluca
Elgilani, Faysal
Longet, Stephanie
Deeks, Alexandra
Payne, Rebecca P
Duncan, Christopher J A
Richter, Alex
de Silva, Thushan I
Turtle, Lance
Bull, Katherine
Barnardo, Martin
Friend, Peter J
Dunachie, Susanna J
Hester, Joanna
Issa, Fadi
Barnes, Eleanor
Carroll, Miles W
Klenerman, Paul
Publication date
2022-03-31
Metadata
Show full item recordAbstract
Patients on hemodialysis (HD) are vulnerable to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and mount poor neutralizing antibody responses after two-dose vaccination. Although serological responses have been associated with reduced rates of reinfection, the relationship between cellular immunogenicity and protection has not been established. We report, for the first time, high incidence of reinfection in patients on HD who are vaccine naive (25%), which identifies that T cell responses do not predict protection against reinfection. Instead, patients on HD who went on to become reinfected had mounted highly variable and sometimes robust proliferative T cell responses to a broad array of SARS-CoV-2 peptide pools during the primary infection. The understanding that SARS-CoV-2–specific T cell responses are not predictive of protection against future infection will be a critical issue when measuring clinical efficacy of vaccination in these vulnerable cohorts, particularly when facing rapidly emerging variants of concern.Citation
Shankar S, Beckett J, Tipton T, Ogbe A, Kasanyinga M, Dold C, Lumley S, Dengu F, Rompianesi G, Elgilani F, Longet S, Deeks A, Payne RP, Duncan CJA, Richter A, de Silva TI, Turtle L, Bull K, Barnardo M, Friend PJ, Dunachie SJ, Hester J, Issa F, Barnes E, Carroll MW, Klenerman P. SARS-CoV-2-Specific T Cell Responses Are Not Associated with Protection against Reinfection in Hemodialysis Patients. J Am Soc Nephrol. 2022 May;33(5):883-887. doi: 10.1681/ASN.2021121587. Epub 2022 Mar 31Type
ArticleAdditional Links
http://www.jasn.org/PMID
35361708Publisher
Wolters Kluwer Healthae974a485f413a2113503eed53cd6c53
10.1681/ASN.2021121587